Corcept Therapeutics | CORT - Cost Of Sales



Corcept Therapeutics reported $3.43M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Acadia Pharmaceuticals USD 20.73M 342K Jun/2025
Alaunos Therapeutics 0 18K Sep/2024
ANI Pharmaceuticals USD 97.9M 24.86M Jun/2025
Ardelyx USD 14.82M 3.44M Jun/2025
Aurora Cannabis CAD 70.07M 8.78M Jun/2025
BioMarin Pharmaceutical USD 154.94M 3.38M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Canopy Growth CAD 54.1M 3.44M Jun/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
J&J USD 7.6B 304M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Merck USD 2.82B 53M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Novartis USD 3.32B 5M Jun/2025
Pacira USD 55.19M 20.88M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Supernus Pharmaceuticals USD 37.65M 21.88M Jun/2025
TG Therapeutics USD 18.94M 3.4M Jun/2025